Fundraising FoxCoLucid Pharmaceuticals
Durham, US · Delaware corporation · 4 known investors
Find your way into CoLucid Pharmaceuticals
Sign up to see every warm intro you have to CoLucid Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the CoLucid Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
BK
Bernice KucaExecutive
MP
Mathers P. ThomasExecutive
NR
Nadia RupniakExecutive
TC
Timothy C. GuptonExecutive
Board
Investors · 4
Domain AssociatesreportedPrinceton · $200K – $15Mvia Jesse Treu · board
How we know: a partner's Signal profile · board seat on SEC Form D · funding news · Not right? Tell us
TVM CapitalinferredMunich · $1.1M – $16.2Mvia Luc Marengère · board
How we know: board seat on SEC Form D · Not right? Tell us
TVM Capital Life SciencereportedMontreal, Quebec
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$37.1M disclosed across 1 round · 2015
▶$37.1MraisedJan 2015 · 11 investors · PharmaceuticalsRule 506(b)
▶$37.1MraisedJan 2015 · 11 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Bernice KucaExecutive Officer
- Mathers P. ThomasExecutive Officer, Director
- Jesse I. TreuDirector
- Nadia RupniakExecutive Officer
- Timothy C. GuptonExecutive Officer
- Richard J. MarkhamDirector
- Arthur M. PappasExecutive Officer, Director
- Martin EdwardsDirector
- Luc MarengereDirector
- Offering amount
- $37.1M
- Amount sold
- $37.1M
- First sale
- Jan 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are CoLucid Pharmaceuticals's investors?
- CoLucid Pharmaceuticals's investors include Pappas Capital, Domain Associates, TVM Capital, TVM Capital Life Science.
- How much funding has CoLucid Pharmaceuticals raised?
- CoLucid Pharmaceuticals has disclosed $37.1M raised across 1 round.
- Where is CoLucid Pharmaceuticals headquartered?
- CoLucid Pharmaceuticals is headquartered in Durham, US.